Division of Climate and Environmental Health, Norwegian Institute of Public Health, 0456, Oslo, Norway; Faculty of Medicine, University of Oslo, Oslo, Norway.
BioDetection Systems BV, Science Park 406, 1098XH, Amsterdam, the Netherlands.
Environ Res. 2022 Nov;214(Pt 1):113861. doi: 10.1016/j.envres.2022.113861. Epub 2022 Jul 9.
The etiology of cryptorchidism remains poorly understood. Endocrine disrupting chemicals can impact estrogen signaling by interacting with aryl hydrocarbon receptor (AhR) activity.
To evaluate whether AhR activity in breast milk samples is associated with cryptorchidism.
We conducted a case-control study based on 199 mother-child pairs (n = 91 cases/108 controls) selected from the Norwegian Human Milk Study (2002-2009). We defined cases for cryptorchidism based on maternal reports at 1-, 6-, 12-, and 24- months after birth. Chemically- and biologically stable AhR activity (pg 2,3,7,8-TCDD equivalent (TEQ)/g lipid) was determined by DR- CALUX® assay in the mothers' milk collected at a median of 33 (10th-90th percentile: 18-57) days after delivery. We used multivariate logistic regression to compare AhR activity levels between cases and controls, and linear regression separately, to establish the relationship with the presence of 27 potential EDCs measured in breast milk and AhR activity.
The average estimated daily intake (EDI) of dioxin and (dioxin-like (dl)-compounds via breast milk is 33.7 ± 17.9 pg TEQ/kg bodyweight per day among Norwegian children. There were no significant differences in AhR activation in breast milk samples between cases with cryptorchidism and controls. Among the 27 chemicals measured in breast milk, AhR activity was (borderline) significantly associated with all dl-PCBs, three non-dioxin-like (ndl)-PCBs (PCB-74, PCB-180, PCB-194) and two organochlorine pesticides (OCPs; HCB, β-HCH). No associations between AhR activity and brominated flame retardants (PBDEs) or poly- and perfluoroalkyl substances (PFASs).
No association between AhR activity and cryptorchidism was found among Norwegian boys. The average EDI of dioxin and dl-compounds in exclusively breastfed Norwegian infants remains above the safety threshold and, therefore requires further reduction measures. Consistent with a possible role in the observed AhR activity, all dl-PCBs were associated with AhR activity whereas the association was null for either PBDEs or PFASs.
隐睾症的病因仍不清楚。内分泌干扰化学品可以通过与芳香烃受体(AhR)活性相互作用来影响雌激素信号。
评估母乳样本中的 AhR 活性是否与隐睾症有关。
我们基于 199 对母子(n=91 例/108 例对照)进行了病例对照研究,这些母子来自挪威人乳研究(2002-2009 年)。我们根据母亲在出生后 1、6、12 和 24 个月时的报告定义隐睾症病例。在分娩后中位数为 33 天(第 10 至 90 百分位数:18-57 天)时收集母亲的母乳,并通过 DR-CALUX® 测定法测定母乳中化学和生物稳定的 AhR 活性(pg 2,3,7,8-TCDD 当量(TEQ)/g 脂质)。我们使用多变量逻辑回归比较病例和对照组之间的 AhR 活性水平,并分别使用线性回归来建立与母乳中 27 种潜在 EDC 存在的关系和 AhR 活性。
通过母乳摄入的二恶英和(类二恶英(dl)-化合物的日估计摄入量(EDI)在挪威儿童中每天为 33.7±17.9 pg TEQ/kg 体重。在隐睾症病例和对照组的母乳样本中,AhR 激活没有显著差异。在所测量的 27 种母乳中的化学物质中,AhR 活性与所有 dl-PCBs、三种非二恶英样(ndl)-PCBs(PCB-74、PCB-180、PCB-194)和两种有机氯农药(OCPs;HCB、β-HCH)呈(边界)显著相关。AhR 活性与溴化阻燃剂(PBDEs)或多氟和全氟烷基物质(PFASs)之间没有关联。
在挪威男孩中,未发现 AhR 活性与隐睾症之间存在关联。在完全母乳喂养的挪威婴儿中,二恶英和 dl-化合物的平均 EDI 仍高于安全阈值,因此需要采取进一步的减排措施。与观察到的 AhR 活性可能起作用一致,所有 dl-PCBs 均与 AhR 活性相关,而 PBDEs 或 PFASs 则没有关联。